Omricon Sub-variant Growth, Paxlovid Updates & CBD Research

Written By Guest User

Dr. Samir Gupta on the Omicron sub-variant growing quickly in some countries, dangerous drug interactions of Paxlovid being flagged by experts, and the ongoing research into CBD and COVID-19.

View the segment here.

Guest User
Previous

Sask. premier plans to scrap proof of vaccination requirement by end of February
Next

The Introduction of Paxlovid in Canada